MERS DNA vaccine induces immunity, protects from virus challenge in preclinical model
A synthetic DNA vaccine candidate for Middle East respiratory syndrome coronavirus (MERS-CoV) developed at The Wistar Institute induced potent immune responses and afforded protective efficacy in non-human primate (NHP) models ...
Apr 22, 2021
0
29